• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌(II)异烟肼配合物的抗结核活性

Antitubercular activity of Ru (II) isoniazid complexes.

作者信息

Aguiar Inara de, Tavares Aline, Roveda Antonio C, da Silva Augusto C H, Marino Leonardo B, Lopes Érica O, Pavan Fernando R, Lopes Luiz G F, Franco Douglas W

机构信息

Instituto de Química, Universidade de São Paulo, São Carlos, SP 13566-590, Brazil.

Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista "Julio de Mesquita Filho", Araraquara, SP 14801-902, Brazil.

出版信息

Eur J Pharm Sci. 2015 Apr 5;70:45-54. doi: 10.1016/j.ejps.2015.01.008. Epub 2015 Jan 28.

DOI:10.1016/j.ejps.2015.01.008
PMID:25638418
Abstract

Despite the resistance developed by the Mycobacterium tuberculosis (MTb) strains, isoniazid (INH) has been recognized as one of the best drug for treatment of Tuberculosis (Tb). The coordination of INH to ruthenium metal centers was investigated as a strategy to enhance the activity of this drug against the sensitive and resistant strains of MTb. The complexes trans-Ru(NH3)4(L)(INH) (L=SO2 or NH3) were isolated and their chemical and antituberculosis properties studied. The minimal inhibitory concentration (MIC) data show that Ru(NH3)5(INH) was active in both resistant and sensitive strains, whereas free INH (non-coordinated) showed to be active only against the sensitive strain. The coordination of INH to the metal center in both Ru(NH3)5(INH) and trans-Ru(NH3)4(SO2)(INH) complexes led to a shift in the INH oxidation potential to less positive values compared to free INH. Despite, the ease of oxidation of INH did not lead to an increase in the in vitro INH activity against MTb, it might have provided sensitivity toward resistant strains. Furthermore, ruthenium complexes with chemical structures analogous to those described above were synthesized using the oxidation products of INH as ligands (namely, isonicotinic acid and isonicotinamide). These last compounds were not active against any strains of MTb. Moreover, according to DFT calculations the formation of the acyl radical, a proposed intermediate in the INH oxidation, is favored in the Ru(NH3)5(INH) complex by 50.7kcalmol(-1) with respect to the free INH. This result suggests that the stabilization of the acyl radical promoted by the metal center would be a more important feature than the oxidation potential of the INH for the antituberculosis activity against resistant strains.

摘要

尽管结核分枝杆菌(MTb)菌株产生了耐药性,但异烟肼(INH)仍被认为是治疗结核病(Tb)的最佳药物之一。研究了INH与钌金属中心的配位情况,以此作为增强该药物对MTb敏感菌株和耐药菌株活性的一种策略。分离出了配合物反式-[Ru(NH₃)₄(L)(INH)]²⁺(L = SO₂或NH₃),并研究了它们的化学性质和抗结核特性。最低抑菌浓度(MIC)数据表明,[Ru(NH₃)₅(INH)]²⁺对耐药菌株和敏感菌株均有活性,而游离INH(未配位)仅对敏感菌株有活性。与游离INH相比,INH在[Ru(NH₃)₅(INH)]²⁺和反式-[Ru(NH₃)₄(SO₂)(INH)]²⁺配合物中与金属中心的配位导致INH氧化电位向更正的值移动。尽管INH易于氧化并未导致其对MTb的体外活性增加,但它可能赋予了对耐药菌株的敏感性。此外,使用INH的氧化产物作为配体(即异烟酸和异烟酰胺)合成了化学结构与上述类似的钌配合物。这些最后合成的化合物对任何MTb菌株均无活性。此外,根据密度泛函理论(DFT)计算,相对于游离INH,在[Ru(NH₃)₅(INH)]²⁺配合物中,酰基自由基(一种在INH氧化过程中提出的中间体)的形成比游离INH更有利,能量差为50.7千卡/摩尔。该结果表明,对于抗耐药菌株的抗结核活性而言,金属中心促进的酰基自由基的稳定化比INH的氧化电位更为重要。

相似文献

1
Antitubercular activity of Ru (II) isoniazid complexes.钌(II)异烟肼配合物的抗结核活性
Eur J Pharm Sci. 2015 Apr 5;70:45-54. doi: 10.1016/j.ejps.2015.01.008. Epub 2015 Jan 28.
2
[A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].[采用肉汤微量稀释法(BrothMIC MTB-1)对0.1微克/毫升异烟肼耐药结核分枝杆菌菌株的研究]
Kekkaku. 2002 Jul;77(7):533-5.
3
Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.异烟肼及其衍生物的铁(II)配合物的合成及反应机理研究:一种基于氧化还原介导的抗结核治疗激活策略。
J Inorg Biochem. 2018 Feb;179:71-81. doi: 10.1016/j.jinorgbio.2017.11.013. Epub 2017 Nov 21.
4
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.具有强效抗结核活性的新型异烟肼衍生物的设计、合成及生物学评价
Eur J Med Chem. 2014 Jun 23;81:119-38. doi: 10.1016/j.ejmech.2014.04.077. Epub 2014 Apr 29.
5
Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activity.鉴于异烟肼的体外活性,目前其在结核病化疗中的应用受到关注。
Microb Drug Resist. 2003 Fall;9(3):313-6. doi: 10.1089/107662903322286535.
6
Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.新型N-(取代)-2-异烟酰肼基碳硫酰胺对耐异烟肼结核病具有高活性的抗分枝杆菌活性。
Biomed Pharmacother. 2009 Jan;63(1):36-9. doi: 10.1016/j.biopha.2008.01.012. Epub 2008 Feb 25.
7
In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.异烟肼酰化衍生物对结核分枝杆菌的体外和体内活性
Drug Des Discov. 2003;18(4):103-8.
8
Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.微波辅助一锅法合成高效新型异烟肼类似物。
Bioorg Med Chem Lett. 2011 Apr 1;21(7):2125-8. doi: 10.1016/j.bmcl.2011.01.122. Epub 2011 Feb 2.
9
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.N-取代2-氨基噻唑衍生物作为抗结核药物的设计、合成及构效关系研究
Eur J Med Chem. 2014 Jan 24;72:26-34. doi: 10.1016/j.ejmech.2013.11.007. Epub 2013 Nov 13.
10
Isoniazid derivatives and their anti-tubercular activity.异烟肼衍生物及其抗结核活性。
Eur J Med Chem. 2017 Jun 16;133:255-267. doi: 10.1016/j.ejmech.2017.04.002. Epub 2017 Apr 3.

引用本文的文献

1
Metal-Peptide Complexes as Promising Antibiotics to Fight Emerging Drug Resistance: New Perspectives in Tuberculosis.金属-肽复合物作为对抗新出现的耐药性的有前景的抗生素:结核病的新视角
Antibiotics (Basel). 2020 Jun 18;9(6):337. doi: 10.3390/antibiotics9060337.
2
A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by .一种纳米结构脂质体系,用于提高钌(II)配合物的口服生物利用度,以治疗由……引起的感染。
Front Microbiol. 2018 Dec 6;9:2930. doi: 10.3389/fmicb.2018.02930. eCollection 2018.
3
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in ?
IQG-607是否是一种具有明确分子靶点的潜在金属药物或前体金属药物?
Front Microbiol. 2018 May 1;9:880. doi: 10.3389/fmicb.2018.00880. eCollection 2018.